SciELO - Scientific Electronic Library Online

 
vol.21 número2What patients with bipolar disorder and major depressive disorder perceive as adverse life events precipitating a current major depressive episodeSociotropic personality traits positively correlate with the severity of social anxiety índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • En proceso de indezaciónSimilares en Google

Compartir


South African Journal of Psychiatry

versión On-line ISSN 2078-6786
versión impresa ISSN 1608-9685

Resumen

DU TOIT, E et al. SSRI use in pregnancy: Evaluating the risks and benefits. S. Afr. j. psyc. [online]. 2015, vol.21, n.2, pp.48-53. ISSN 2078-6786.  http://dx.doi.org/10.7196/SAJP587.

Selective serotonin reuptake inhibitor (SSRI) antidepressants are considered the primary pharmacological treatment for moderate to severe depression during pregnancy. Data regarding the safety of their use during pregnancy remain controversial and conflicting. Decisions regarding the prescription of antidepressant treatment are often fraught with concern around potential harmful medication effects on the pregnancy, fetus and infant. Information on potential risks remains extremely varied and inconsistent across sources. This lack of clarity regarding drug safety brings significant uncertainty not only for treating physicians, but also for women seeking information about depression during pregnancy. This review aims to summarise and evaluate the current evidence base and to aid clinicians in performing a risk/benefit analysis for SSRI use during pregnancy and lactation.

        · texto en Inglés     · Inglés ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons